Heron Therapeutics reported $52.24M in Stock for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Alnylam Pharmaceuticals ALNY:US USD 115.49M 26.51M
Amarin AMRN:US USD 227.61M 1.83M
Ani Pharmaceuticals ANIP:US USD 95.89M 3.35M
Anika Therapeutics ANIK:US USD 37.24M 1.9M
Eisai 4523:JP JPY 114.41B 10.9B
Emergent Biosolutions EBS:US USD 546.3M 120.8M
Endo International Ordinary Shares ENDP:US USD 288.91M 1.16M
Esperion Therapeutics ESPR:US USD 29.54M 313K
GlaxoSmithKline GSK:LN GBP 4.66B 5M
Heron Therapeutics HRTX:US USD 52.24M 9.08M
Insmed INSM:US USD 66.28M 741K
JAZZ PHA JAZZ:US USD 728.07M 133.63M
Ligand Pharmaceuticals LGND:US USD 22.33M 2.45M
Nektar Therapeutics NKTR:US USD 19.06M 2.09M
Neurocrine Biosciences NBIX:US USD 37M 7.7M
Pacira Pharmaceuticals PCRX:US USD 96.8M 3.79M
Regeneron Pharmaceuticals REGN:US USD 2.41B 193.7M
Roche Holding ROG:VX 8.29B 577M
Surmodics SRDX:US USD 11.82M 893K
Teva Pharmaceutical Industries TEVA:US USD 3.86B 190M
Ultragenyx Pharmaceutical RARE:US USD 21.85M 770K
Veracyte VCYT:US USD 13.8M 802K
Vertex Pharmaceuticals VRTX:US USD 388.2M 20.5M